CNMD - コンメド (CONMED Corporation)

CNMDのニュース

   CONMED Corporation Announces That 2020 Annual Meeting of Shareholders Will Be Virtual-Only Meeting Due to COVID-19  2020/05/11 11:00:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its 2020 Annual Meeting of Shareholders, scheduled for May 21, 2020, at 1:30 p.m. ET, will be hosted as a virtual-only meeting due to public health concerns and social-distancing restrictions imposed by governmental authorities with respect to non-essential gatherings arising from the COVID-19 pandemic. Information about the virtual meeting webcast and instructions for how shareholders can participate in the Annu
   Outlook into the Worldwide Electrosurgery Devices Industry to 2025 - Featuring Johnson & Johnson, Conmed & Stryker Among Others - ResearchAndMarkets.com  2020/05/07 13:17:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Global Electrosurgery Devices Market By Product (Electrosurgical Generators, Electrosurgical Instruments, Accessories), By Application, By End-user, By Region, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering. The Global Electrosurgery Devices Market is expected to grow at a steady rate during the forecast period. Growing trend of plastic surgeries, initiated by the celebrities to look younger has influenced a large par
   CONMED Corporation to Present at the BofA Securities Virtual Healthcare Conference  2020/05/04 20:05:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the BofA Securities Virtual Healthcare Conference at 9:40 a.m. ET on Tuesday, May 12, 2020. A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.conmed.com and will be available for replay following the ev
   Conmed (CNMD) Q1 Earnings and Revenues Top Estimates  2020/04/29 21:35:14 Zacks Investment Research
Conmed (CNMD) delivered earnings and revenue surprises of 15.91% and 2.60%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
   CONMED Corporation Announces First Quarter 2020 Financial Results  2020/04/29 20:05:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2020. First Quarter 2020 Highlights Sales of $214.0 million decreased 2.0% year over year as reported and 0.7% in constant currency. Acquisitions contributed approximately 290 basis points of growth. Domestic revenue increased 1.6% year over year. International revenue decreased 6.1% as reported and 3.4% in constant currency. Diluted net earnings per share (GAAP)
   CONMED (CNMD) Earnings and Revenues Beat Estimates in Q4  2020/01/31 08:37:00 Zacks Investment Research
CONMED's (CNMD) fourth-quarter earnings gain from higher revenues and strong performance in General Surgery segment. However, high long-term debt remains a concern.
   CONMED Corporation to Transfer Listing of Common Stock to the New York Stock Exchange  2020/01/29 21:03:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ: CNMD) today announced that it is transferring the listing of its common stock to the New York Stock Exchange (NYSE) from the NASDAQ Global Market. CONMED expects to begin trading on the NYSE effective at the open of markets on February 10, 2020. The Company’s shares will continue to trade on the NASDAQ until the transfer is completed and will continue to trade under the ticker “CNMD” as part of the transfer to the NYSE. “We are excited t
   CONMED Corporation Announces Fourth Quarter and Full-Year 2019 Financial Results  2020/01/29 21:01:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (Nasdaq: CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2019. Fourth Quarter 2019 Highlights Sales of $264.9 million increased 9.2% year over year as reported and 9.3% in constant currency. Acquisitions contributed approximately 670 basis points of growth. Domestic revenue increased 13.8% year over year. International revenue increased 4.4% as reported and 4.5% in constant currency. Operating margi
   CONMED Corporation to Announce Fourth Quarter and Full-Year 2019 Financial Results on January 29, 2020  2020/01/06 21:01:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the fourth quarter and full year 2019 after the market close on Wednesday, January 29, 2020. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call, dial 1-844-889-7792 (domestic) or +1-661-378-9936 (international) and refer to the passcode 2289828. This conference call will also be web
   CONMED Corporation to Present at the J.P. Morgan Healthcare Conference  2020/01/02 21:01:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference at 4:30 p.m. PT on Monday, January 13, 2020 in San Francisco, CA. A live webcast of the presentation and Q&A breakout session will be accessible through the “Investors” section of the Company’s website at www.conme
   CONMED (CNMD) Earnings and Revenues Beat Estimates in Q4  2020/01/31 08:37:00 Zacks Investment Research
CONMED's (CNMD) fourth-quarter earnings gain from higher revenues and strong performance in General Surgery segment. However, high long-term debt remains a concern.
   CONMED Corporation to Transfer Listing of Common Stock to the New York Stock Exchange  2020/01/29 21:03:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ: CNMD) today announced that it is transferring the listing of its common stock to the New York Stock Exchange (NYSE) from the NASDAQ Global Market. CONMED expects to begin trading on the NYSE effective at the open of markets on February 10, 2020. The Company’s shares will continue to trade on the NASDAQ until the transfer is completed and will continue to trade under the ticker “CNMD” as part of the transfer to the NYSE. “We are excited t
   CONMED Corporation Announces Fourth Quarter and Full-Year 2019 Financial Results  2020/01/29 21:01:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (Nasdaq: CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2019. Fourth Quarter 2019 Highlights Sales of $264.9 million increased 9.2% year over year as reported and 9.3% in constant currency. Acquisitions contributed approximately 670 basis points of growth. Domestic revenue increased 13.8% year over year. International revenue increased 4.4% as reported and 4.5% in constant currency. Operating margi
   CONMED Corporation to Announce Fourth Quarter and Full-Year 2019 Financial Results on January 29, 2020  2020/01/06 21:01:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ: CNMD) today announced that it will report financial results for the fourth quarter and full year 2019 after the market close on Wednesday, January 29, 2020. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call, dial 1-844-889-7792 (domestic) or +1-661-378-9936 (international) and refer to the passcode 2289828. This conference call will also be web
   CONMED Corporation to Present at the J.P. Morgan Healthcare Conference  2020/01/02 21:01:00 Business Wire
UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NASDAQ: CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 38th Annual J.P. Morgan Healthcare Conference at 4:30 p.m. PT on Monday, January 13, 2020 in San Francisco, CA. A live webcast of the presentation and Q&A breakout session will be accessible through the “Investors” section of the Company’s website at www.conme

calendar